Are you Dr. Hodges?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 64 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
234 Goodman St
Cincinnati, OH 45219Phone+1 513-584-3494Fax+1 513-584-3807
Summary
- Dr. Kurt Hodges, MD is a board certified pathologist in Cincinnati, Ohio. He is currently licensed to practice medicine in Ohio, Alaska, and California. He is affiliated with University of Cincinnati Medical Center and is an Associate Professor at Indiana University School of Medicine.
Education & Training
- Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1993 - 1997
- University of Tennessee Medical Center at KnoxvilleInternship, Transitional Year, 1992 - 1993
- University of Texas Southwestern Medical CenterResidency, Surgery, 1991 - 1991
- University of Texas Southwestern Medical SchoolClass of 1991
Certifications & Licensure
- HI State Medical License 2023 - 2026
- MD State Medical License 2021 - 2026
- NE State Medical License 2021 - 2026
- OH State Medical License 2018 - 2026
- TN State Medical License 2021 - 2026
- WV State Medical License 2021 - 2026
- AZ State Medical License 2020 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Pathology - Molecular Genetic
- Join now to see all
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 32 citationsElevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary glandIliana Tenvooren, Mónica Z. Jenks, Hamza Rashid, Katherine L. Cook, Joëlle K. Muhlemann
Oncogene. 2019-01-22 - 55 citationsTargeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.Caterina Bartolacci, Cristina Andreani, Gonçalo Vale, Stefano Berto, Margherita Melegari
Nature Communications. 2022-07-26 - 32 citationsInhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.Chen Shao, Nihal Ahmad, Kurt B. Hodges, Shihuan Kuang, Timothy L. Ratliff
The Journal of Biological Chemistry. 2015-01-23